Literature DB >> 21400573

Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines.

Hejun Zhang1, Xiangling Feng, Weidong Liu, Xingjun Jiang, Wenjiao Shan, Chengan Huang, Hongmei Yi, Bin Zhu, Wen Zhou, Lei Wang, Chunmei Liu, Lihua Zhang, Wenting Jia, Wei Huang, Guifei Li, Jia Shi, Siyi Wanggou, Kaitai Yao, Caiping Ren.   

Abstract

The lactoferrin (LTF) gene, located at 3p21.3, behaves like a tumor suppressor gene in diverse tumors. To elucidate the exact role of LTF in NPC, we first detected its expression level in seven NPC cell lines by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). The results showed the mRNA level of LTF was nearly undetectable in all the seven NPC cell lines, while it could be detected in chronic nasopharyngitis tissues. Subsequently, we used methylation-specific PCR (MSP), microsatellite assay, PCR-single-strand conformation polymorphism (PCR-SSCP) and sequencing methods to examine the promoter methylation, loss of heterozygosity (LOH) and gene mutation of LTF in NPC cell lines respectively. Consequently, we found that 100% (7 of 7) of NPC cell lines were methylated in LTF promoter, only one cell line (14%, 1 of 7) had LOH and gene mutation of LTF, respectively, while LTF exhibited re-expression in all cell lines after 5-aza-dC treatment, indicating promoter methylation should be the key mechanism causing LTF downregulation in NPC cell lines. Furthermore, patched methylation assay confirmed that promoter methylation could down-regulate LTF gene expression in NPC cells. Finally, we investigated the function of LTF in NPC cell lines by gene transfection. Restoration of LTF expression in NPC cells resulted in blockage of cell cycle progression, significant inhibition of cell growth and a reduced colony-formation capacity in vitro and obviously weaker tumor formation potential in vivo. In conclusion, our data indicate LTF may participate in NPC carcinogenesis as a negative effector, that is, a tumor suppressor gene.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21400573     DOI: 10.1002/jcb.23101

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Aspirin insensitive thrombophilia: transcript profiling of blood identifies platelet abnormalities and HLA restriction.

Authors:  Payam Fallahi; Richard Katz; Ian Toma; Ranyang Li; Jonathan Reiner; Kiersten VanHouten; Larry Carpio; Lorraine Marshall; Yi Lian; Sujata Bupp; Sidney W Fu; Frederick Rickles; David Leitenberg; Yinglei Lai; Babette B Weksler; Frederik Rebling; Zhaoqing Yang; Timothy A McCaffrey
Journal:  Gene       Date:  2013-02-27       Impact factor: 3.688

2.  miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.

Authors:  Min Deng; Qiurong Ye; Zailong Qin; Ying Zheng; Wei He; Hailin Tang; Yanhong Zhou; Wei Xiong; Ming Zhou; Xiaoling Li; Qun Yan; Jian Ma; Guiyuan Li
Journal:  Tumour Biol       Date:  2013-03-13

3.  Identification of ABCG2⁺ cells in nasopharyngeal carcinoma cells.

Authors:  Hongbo Zhang; Weidong Liu; Xiangling Feng; Lei Wang; Xingjun Jiang; Dingyang Liu; Lihua Zhang; Bin Zhu; Wen Zhou; Wenting Jia; Guifei Li; Caiping Ren
Journal:  Oncol Rep       Date:  2011-12-30       Impact factor: 3.906

Review 4.  Tumor suppressor genes on frequently deleted chromosome 3p in nasopharyngeal carcinoma.

Authors:  Juan Chen; Li Fu; Li-Yi Zhang; Dora L Kwong; Li Yan; Xin-Yuan Guan
Journal:  Chin J Cancer       Date:  2012-02-24

5.  Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways.

Authors:  Jie Liu; Wei Huang; Caiping Ren; Qiuyuan Wen; Weidong Liu; Xuyu Yang; Lei Wang; Bin Zhu; Liang Zeng; Xiangling Feng; Chang Zhang; Huan Chen; Wei Jia; Lihua Zhang; Xiaomeng Xia; Yuxiang Chen
Journal:  Sci Rep       Date:  2015-07-24       Impact factor: 4.379

6.  CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.

Authors:  Wenting Jia; Caiping Ren; Lei Wang; Bin Zhu; Wei Jia; Menghui Gao; Fei Zeng; Liang Zeng; Xiaomeng Xia; Xiaobing Zhang; Ting Fu; Shasha Li; Can Du; Xingjun Jiang; Yuxiang Chen; Weihong Tan; Zilong Zhao; Weidong Liu
Journal:  Oncotarget       Date:  2016-08-23

7.  Development of an Immune-Related Gene Signature for Prognosis in Melanoma.

Authors:  Jia-An Zhang; Xu-Yue Zhou; Dan Huang; Chao Luan; Heng Gu; Mei Ju; Kun Chen
Journal:  Front Oncol       Date:  2021-01-21       Impact factor: 6.244

8.  Identification of potential gene signatures associated with osteosarcoma by integrated bioinformatics analysis.

Authors:  Yutao Jia; Yang Liu; Zhihua Han; Rong Tian
Journal:  PeerJ       Date:  2021-05-27       Impact factor: 2.984

9.  Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma.

Authors:  Wen Zhou; Xiangling Feng; Caiping Ren; Xingjun Jiang; Weidong Liu; Wei Huang; Zhihong Liu; Zan Li; Liang Zeng; Lei Wang; Bin Zhu; Jia Shi; Jie Liu; Chang Zhang; Yanyu Liu; Kaitai Yao
Journal:  Mol Cancer       Date:  2013-06-08       Impact factor: 27.401

10.  PLCD3, a flotillin2-interacting protein, is involved in proliferation, migration and invasion of nasopharyngeal carcinoma cells.

Authors:  Weidong Liu; Xuxu Liu; Lei Wang; Bin Zhu; Chang Zhang; Wei Jia; Hecheng Zhu; Xingdong Liu; Meizuo Zhong; Dan Xie; Yanyu Liu; Shasha Li; Jia Shi; Jianxing Lin; Xiaomeng Xia; Xingjun Jiang; Caiping Ren
Journal:  Oncol Rep       Date:  2017-11-06       Impact factor: 3.906

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.